Indiana Palliative Excellence in Alzheimer Care Efforts-RCT
印第安纳州姑息治疗阿尔茨海默病护理工作的卓越成果-随机对照试验
基本信息
- 批准号:10394808
- 负责人:
- 金额:$ 68.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvance Care PlanningAdverse effectsAffectAge-YearsAggressive behaviorAgitationAlzheimer&aposs DiseaseAlzheimer&aposs disease careAlzheimer&aposs disease related dementiaAmericanAnxietyBlindedCaregiver BurdenCaregiver supportCaregiversCaringCause of DeathClinicalCollaborationsCommunitiesCommunity ServicesComprehensive Health CareControl GroupsDementiaDementia caregiversDepressed moodDistressEmergency department visitEnrollmentEnsureEquipment and supply inventoriesEvidence based interventionFamilyFamily CaregiverFamily memberFutureGoalsHealthHealth systemHomeHospitalizationHospitalsIndianaInterdisciplinary StudyInterventionInterviewModelingMoodsNatureNetwork-basedNursing HomesOutcomeOutcome AssessmentPainPain managementPalliative CarePatient CarePatientsPersonsPharmaceutical PreparationsPopulationPrevalenceProtocols documentationProviderPublic HealthRandomizedRandomized Controlled TrialsReactionResearchResearch AssistantRiskShapesShoulderSocial WorkersSocietiesStressSupportive careSymptomsTelephoneTestingTimeUnited StatesWorkbasecare providerscare systemscommunity settingdementia careempoweredend of lifeevidence baseexperiencefamily supportfeedinghospice environmentimprovedinnovationintervention effectmeetingsmulti-component interventionmultidisciplinaryneuropsychiatric symptomneuropsychiatrypalliativepersonalized carepreferencerecruitrepetitive behaviorsymptom managementtreatment as usualtreatment grouptreatment planningtrial comparingusual care arm
项目摘要
PROJECT SUMMARY/ABSTRACT
Dementia is a prevalent, growing public health problem; over 5 million Americans suffer from the condition and
up to 16 million people are projected to be affected by 2050. Neuropsychiatric symptoms in dementia are often
treated with medications having greater evidence of adverse effects than benefits. Patients with dementia are
at risk for inadequate recognition and management of pain; receive burdensome treatments; and suffer with
insufficient involvement of palliative care services. Family caregivers receive inadequate support in the face of
substantial stress. Patients and families are poorly served by interventions and models that present dementia-
specific care and palliative care as mutually exclusive options. The overarching goal of this research by Dr.
Sachs’s team is to improve the care of community dwelling patients with dementia and their family caregivers
through an innovative model of supportive care that combines an existing, evidence-based intervention for
dementia care with an innovative intervention for palliative care in dementia. The intervention projects this care
into the homes of patients and caregivers, empowering caregivers, and integrating with ongoing care. The
proposed randomized controlled trial compares the IN-PEACE intervention (Indiana version of Palliative
Excellence in Alzheimer Care Efforts) to usual care for community dwelling patients with moderate to severe
dementia and their family caregivers. IN-PEACE will enroll 200 patient-caregiver dyads, randomizing 100
dyads each to the intervention and usual care arms and follow for 24 months with outcome assessments at 3,
6, 9, 12, 15, 18, 21 and 24 months by research assistants blinded to treatment group. The core of the multi-
component intervention is regular, proactive telephone contact by a dementia care coordinator (DCC; social
worker or RN) to anticipate and identify patients’ symptoms and caregivers needs and address them utilizing
specific, evidence-based protocols. Protocols cover basic dementia care, caregiver distress, neuropsychiatric
symptoms, pain, navigating the hospital, feeding difficulties, and transition to hospice. The intervention also
involves advance care planning and support with caregivers tailored to decisions faced in dementia care,
highlighting where palliative care options can replace the default that often results in burdensome treatments.
DCCs are supported by weekly meetings of the interdisciplinary research team, as well as collaboration with
patients’ primary care providers and community services. The primary aim of IN-PEACE is to test the effect of
the intervention on patients’ neuropsychiatric symptoms. Other aims include testing the effect of IN-PEACE on
patients’ overall symptom outcomes, caregiver mood and distress, and the provision of burdensome
treatments to patients (hospitalizations and emergency room visits). IN-PEACE is based on an innovative
supportive care model; utilizes an innovative intervention that integrates evidence-based dementia care and
palliative care; and is fielded in an innovative practice based network that focuses on enhancing dementia care
in the community. This will be the first study of its kind, reshaping the nature of future interventions in this field.
项目总结/摘要
痴呆症是一种普遍的、日益严重的公共卫生问题;超过500万美国人患有这种疾病,
预计到2050年将有多达1 600万人受到影响。痴呆症的神经精神症状通常
用药物治疗,其副作用的证据大于益处。痴呆症患者
存在对疼痛认识和管理不足的风险;接受繁重的治疗;并患有
姑息治疗服务参与不足。家庭照顾者在面临
巨大的压力。呈现痴呆症的干预措施和模型对患者和家庭的服务很差-
具体护理和姑息治疗是相互排斥的选择。这项研究的总体目标是由博士。
萨克斯的团队是为了改善社区居住的痴呆症患者和他们的家庭照顾者的护理
通过创新的支持性护理模式,结合现有的,基于证据的干预措施,
老年痴呆症护理与创新的干预措施,为姑息治疗老年痴呆症。干预计划将这种关怀
进入患者和护理人员的家中,赋予护理人员权力,并与持续护理相结合。的
一项拟定的随机对照试验比较了IN-PEACE干预(印第安纳州版本的姑息治疗)和
卓越的阿尔茨海默氏症护理工作),以常规护理社区居住的患者,中度至重度
老年痴呆症及其家庭护理人员。IN-PEACE将入组200名患者-护理人员配对,随机分配100名
干预组和常规护理组各配对,并随访24个月,结果评估为3,
6、9、12、15、18、21和24个月,研究助理对治疗组设盲。核心的多-
成分干预是由痴呆症护理协调员(DCC;社会
工作人员或RN)预测和识别患者的症状和护理人员的需求,并利用
具体的循证治疗方案协议涵盖基本的痴呆症护理,照顾者的痛苦,神经精神
症状,疼痛,在医院导航,喂养困难,过渡到临终关怀。干预还
涉及提前护理规划和支持,护理人员根据痴呆症护理中面临的决定量身定制,
强调姑息治疗方案可以取代通常导致繁重治疗的默认方案。
DCC由跨学科研究团队的每周会议提供支持,并与
患者的初级保健提供者和社区服务。IN-PEACE的主要目的是测试
对患者神经精神症状的干预。其他目标包括测试国际和平组织对
患者的整体症状结果,照顾者的情绪和痛苦,以及负担的提供
患者的治疗(住院和急诊室就诊)。国际和平组织基于一种创新的
支持性护理模式;采用创新的干预措施,整合了基于证据的痴呆症护理,
姑息治疗;并被派往一个创新的实践为基础的网络,重点是加强痴呆症护理
在社区这将是此类研究中的第一次,重塑这一领域未来干预措施的性质。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Indiana Palliative Excellence in Alzheimer's Care Efforts (IN-PEACE): Protocol for a randomized controlled trial in persons with advanced dementia.
印第安纳州阿尔茨海默病姑息治疗卓越计划 (IN-PEACE):针对晚期痴呆症患者的随机对照试验方案。
- DOI:10.1016/j.cct.2023.107217
- 发表时间:2023
- 期刊:
- 影响因子:2.2
- 作者:Holtz,LauraR;Kroenke,Kurt;Gao,Sujuan;Hickman,SusanE;Torke,AlexiaM;Johnson,NinaM;Pemberton,Amy;Vrobel,Andrea;Pan,Minmin;Sachs,GregA
- 通讯作者:Sachs,GregA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREG A SACHS其他文献
GREG A SACHS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREG A SACHS', 18)}}的其他基金
Ethics of Medication Deprescribing in Dementia Care
痴呆症护理中药物处方的伦理
- 批准号:
9929264 - 财政年份:2018
- 资助金额:
$ 68.05万 - 项目类别:
Indiana Palliative Excellence in Alzheimer Care Efforts-RCT
印第安纳州姑息治疗阿尔茨海默病护理工作的卓越成果-随机对照试验
- 批准号:
9924430 - 财政年份:2018
- 资助金额:
$ 68.05万 - 项目类别:
Optimal Prevention & Treatment In Medically Complex Alzheimer Patients (OPTIMAL)
最佳预防
- 批准号:
7534918 - 财政年份:2008
- 资助金额:
$ 68.05万 - 项目类别:
Optimal Prevention & Treatment In Medically Complex Alzheimer Patients (OPTIMAL)
最佳预防
- 批准号:
7666801 - 财政年份:2008
- 资助金额:
$ 68.05万 - 项目类别:
How Exam Rooms Enhance Physicians' Patient-Centeredness
检查室如何增强医生以患者为中心的态度
- 批准号:
6831390 - 财政年份:2004
- 资助金额:
$ 68.05万 - 项目类别:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
痴呆症研究:知情、代理和事先同意
- 批准号:
2545183 - 财政年份:1997
- 资助金额:
$ 68.05万 - 项目类别:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
痴呆症研究:知情、代理和事先同意
- 批准号:
2904301 - 财政年份:1997
- 资助金额:
$ 68.05万 - 项目类别:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
痴呆症研究:知情、代理和事先同意
- 批准号:
6335281 - 财政年份:1997
- 资助金额:
$ 68.05万 - 项目类别:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
痴呆症研究:知情、代理和事先同意
- 批准号:
2769442 - 财政年份:1997
- 资助金额:
$ 68.05万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 68.05万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 68.05万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 68.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 68.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 68.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)